Ilaris

Made by

• Novartis

Active Ingredient

Canakinumab

Prospectus

Approval date

2011/9/26

Treats

• Tumor necrosis factor receptor-associated periodic syndrome, Familial periodic fever
• Cryopyrin associated periodic syndrome
• Mevalonate kinase deficiency
• Familial Mediterranean fever, Familial hereditary periodic fever syndromes
• Familial cold autoinflammatory syndrome, Familial cold urticaria
• Juvenile idiopathic arthritis

Dosages

• ILARIS solution for s.c.injection 150mg - 1526075円／瓶